The combined role of immunomodulators (IMM) and clinical characteristics of Inflammatory bowel disease (IBD) in determining the cancer risk is undefined. The aim was to assess whether clinical characteristics of IBD are independent risk factors for cancer, when considering thiopurines and anti-TNFs use.
Biancone, L., Zuzzi, S., Ranieri, M., Petruzziello, C., Calabrese, E., Onali, S., et al. (2012). Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study. JOURNAL OF CROHN'S AND COLITIS, 6(5), 578-587 [10.1016/j.crohns.2011.11.005].
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study
BIANCONE, LIVIA;ZUZZI, SARA;CALABRESE, EMMA;IACOBELLI, SIMONA;PALLONE, FRANCESCO
2012-06-01
Abstract
The combined role of immunomodulators (IMM) and clinical characteristics of Inflammatory bowel disease (IBD) in determining the cancer risk is undefined. The aim was to assess whether clinical characteristics of IBD are independent risk factors for cancer, when considering thiopurines and anti-TNFs use.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Fistulizing pattern in Crohn's disease and pancolitis.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
500.67 kB
Formato
Adobe PDF
|
500.67 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
